Unapplied Cash Analyst

McKesson; United States; Remote; USD 48,000 - 68,000; Full time

Job summary

Sarah Cannon Research Institute (SCRI), a McKesson subsidiary, seeks an Unapplied Cash Analyst for a remote US-based role. You will support cash application processes within the finance department, reconcile unapplied cash, and collaborate with site teams to verify payment details.

The position emphasizes accuracy, attention to detail, and clear communication as you handle remittances, apply receivables, and maintain CTMS-related entries when needed.

Qualifications

• High School Diploma required, Associate’s Degree highly preferred.
• 1+ year experience in basic financial operations including debits/credits, reconciliation, invoicing, and payment lifecycles.
• Intermediate to advanced MS Excel skills.
• Understanding of payments flow and unapplied cash impact on financials.
• Strong attention to detail, problem solving, and clear communication.

Responsibilities

• Review and reconcile unapplied cash.
• Work with sites to confirm visit activity.
• Enter charges into the CTMS when needed.
• Apply receivables to Cash Receipts Log across lines of business.
• Post cash items in proprietary systems using remittance details from pharma companies.
• Verify remittance data with pharma companies for accuracy.
• Review and interpret payer remittances for data accuracy.

Job description

It’s More Than a Career, It’s a Mission.

Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.

Our Mission

People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world.

Our Unapplied Cash Analyst position is responsible for all cash application functions within the finance department including reviewing and reconciling unapplied cash and will support general areas of operations as well as provide administrative and organizational support.

This is a remote position within the US; relocation assistance and visa sponsorship are not available.

Job Description includes and is not limited to:

• Review and reconcile unapplied cash
• Work closely with sites to confirm visit activity
• Enter charges into the clinical trial management system (CTMS) if/when needed
• Application of receivables to Cash Receipts Log for all lines of business
• Transactional line-item cash posting into proprietary systems based on remittance detail provided by pharmaceutical companies
• Ensure accuracy of cash postings by contacting pharmaceutical companies to verify payment remittance details
• Review, interpret and discuss remittances from payers for data accuracy

Qualifications for success include:

• High School Diploma obtained, Associate’s Degree highly preferred
• 1+ year work experience with basic financial operations including: debits/credits, reconciliation, invoice structures and payment lifecycles
• Intermediate to advanced MS Excel skills
• Understanding of how payments flow, how to match payments to invoices, and how unapplied cash affects financials.
• Additional qualifications include ability to investigate discrepancies, interpret remittances, and resolve unidentified cash. Strong attention to detail, problem solving and clear communication skills.

About Sarah Cannon Research Institute

Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 850 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI’s research network brings together more than 1,300 physicians who are enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S. Please click here to learn more about our research offerings.

We care about the well-being of the patients and communities we serve, and that starts with caring for our people. That’s why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well-being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information regarding benefits through our parent company, McKesson, please click here.

As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long-term incentive opportunities may be offered.

We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.